Jaguar Health (JAGX) Return on Sales (2016 - 2025)
Historic Return on Sales for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 3.13%.
- Jaguar Health's Return on Sales rose 900.0% to 3.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.48%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 3.36% for FY2024, which is 9300.0% up from last year.
- According to the latest figures from Q3 2025, Jaguar Health's Return on Sales is 3.13%, which was up 900.0% from 3.54% recorded in Q2 2025.
- In the past 5 years, Jaguar Health's Return on Sales registered a high of 2.53% during Q4 2022, and its lowest value of 36.57% during Q2 2021.
- Over the past 5 years, Jaguar Health's median Return on Sales value was 4.0% (recorded in 2022), while the average stood at 6.95%.
- In the last 5 years, Jaguar Health's Return on Sales crashed by -336600bps in 2021 and then skyrocketed by 333600bps in 2022.
- Quarter analysis of 5 years shows Jaguar Health's Return on Sales stood at 6.88% in 2021, then soared by 63bps to 2.53% in 2022, then crashed by -60bps to 4.05% in 2023, then rose by 28bps to 2.92% in 2024, then dropped by -7bps to 3.13% in 2025.
- Its Return on Sales was 3.13% in Q3 2025, compared to 3.54% in Q2 2025 and 4.79% in Q1 2025.